KIRBY JOHN J. (Interim CFO) purchased 65.2% of their position (3.54K shares) of VERRICA PHARMACEUTICALS INC. on the open market
Open‑market purchase worth $15.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/25/2025ACC: 0001556327-25-000004
Officer· Interim CFO
Since Nov 2024
+4.42K
Net shares
Net buyer
$15.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
4.42K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.54K
Price / share
$4.24
Trade value
$15K
% of position
65.2%
11/25/2025
5.43K→8.96K
Total
Net shares
+3.54K
Net value
$15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/25/2025 | P · Purchase | +3.54K | $4.24 | $15K | 65.2% | 5.43K | 8.96K |
| Total | +3.54K | $15K | ||||||
Derivative Transactions1
Series C Warrant (right to buy)
Direct
Converts to
Common Stock
884.00 shares
Shares
+884.00
Strike price
6.315
Held after
884.00
Exercisable
—
11/25/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series C Warrant (right to buy) Direct | Common Stock884.00 shares | 11/25/2025 | P · Purchase | +884.00 | 6.315 | — | 884.00 |